PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
BHVN vs. CRWD
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between BHVN and CRWD is 0.26, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

BHVN vs. CRWD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Biohaven Pharmaceutical Holding Company Ltd. (BHVN) and CrowdStrike Holdings, Inc. (CRWD). The values are adjusted to include any dividend payments, if applicable.

0.00%20.00%40.00%60.00%80.00%SeptemberOctoberNovemberDecember2025February
3.95%
76.15%
BHVN
CRWD

Key characteristics

Sharpe Ratio

BHVN:

-0.31

CRWD:

0.83

Sortino Ratio

BHVN:

-0.07

CRWD:

1.35

Omega Ratio

BHVN:

0.99

CRWD:

1.18

Calmar Ratio

BHVN:

-0.41

CRWD:

0.89

Martin Ratio

BHVN:

-0.62

CRWD:

2.19

Ulcer Index

BHVN:

30.12%

CRWD:

18.05%

Daily Std Dev

BHVN:

59.17%

CRWD:

47.37%

Max Drawdown

BHVN:

-45.15%

CRWD:

-67.69%

Current Drawdown

BHVN:

-35.68%

CRWD:

0.00%

Fundamentals

Market Cap

BHVN:

$3.93B

CRWD:

$103.84B

EPS

BHVN:

-$9.26

CRWD:

$0.51

Total Revenue (TTM)

BHVN:

$0.00

CRWD:

$2.90B

Gross Profit (TTM)

BHVN:

-$1.92M

CRWD:

$2.18B

EBITDA (TTM)

BHVN:

-$689.79M

CRWD:

$223.65M

Returns By Period

In the year-to-date period, BHVN achieves a 2.89% return, which is significantly lower than CRWD's 23.21% return.


BHVN

YTD

2.89%

1M

-1.89%

6M

-1.23%

1Y

-18.09%

5Y*

N/A

10Y*

N/A

CRWD

YTD

23.21%

1M

17.53%

6M

75.01%

1Y

30.51%

5Y*

46.82%

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

BHVN vs. CRWD — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BHVN
The Risk-Adjusted Performance Rank of BHVN is 2828
Overall Rank
The Sharpe Ratio Rank of BHVN is 2929
Sharpe Ratio Rank
The Sortino Ratio Rank of BHVN is 2929
Sortino Ratio Rank
The Omega Ratio Rank of BHVN is 2929
Omega Ratio Rank
The Calmar Ratio Rank of BHVN is 2121
Calmar Ratio Rank
The Martin Ratio Rank of BHVN is 3333
Martin Ratio Rank

CRWD
The Risk-Adjusted Performance Rank of CRWD is 7070
Overall Rank
The Sharpe Ratio Rank of CRWD is 7272
Sharpe Ratio Rank
The Sortino Ratio Rank of CRWD is 6767
Sortino Ratio Rank
The Omega Ratio Rank of CRWD is 6767
Omega Ratio Rank
The Calmar Ratio Rank of CRWD is 7676
Calmar Ratio Rank
The Martin Ratio Rank of CRWD is 6767
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

BHVN vs. CRWD - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Biohaven Pharmaceutical Holding Company Ltd. (BHVN) and CrowdStrike Holdings, Inc. (CRWD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for BHVN, currently valued at -0.31, compared to the broader market-2.000.002.004.00-0.310.83
The chart of Sortino ratio for BHVN, currently valued at -0.07, compared to the broader market-4.00-2.000.002.004.00-0.071.35
The chart of Omega ratio for BHVN, currently valued at 0.99, compared to the broader market0.501.001.502.000.991.18
The chart of Calmar ratio for BHVN, currently valued at -0.41, compared to the broader market0.002.004.006.00-0.410.89
The chart of Martin ratio for BHVN, currently valued at -0.62, compared to the broader market-30.00-20.00-10.000.0010.0020.0030.00-0.622.19
BHVN
CRWD

The current BHVN Sharpe Ratio is -0.31, which is lower than the CRWD Sharpe Ratio of 0.83. The chart below compares the historical Sharpe Ratios of BHVN and CRWD, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.502.002.503.00SeptemberOctoberNovemberDecember2025February
-0.31
0.83
BHVN
CRWD

Dividends

BHVN vs. CRWD - Dividend Comparison

Neither BHVN nor CRWD has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

BHVN vs. CRWD - Drawdown Comparison

The maximum BHVN drawdown since its inception was -45.15%, smaller than the maximum CRWD drawdown of -67.69%. Use the drawdown chart below to compare losses from any high point for BHVN and CRWD. For additional features, visit the drawdowns tool.


-40.00%-30.00%-20.00%-10.00%0.00%SeptemberOctoberNovemberDecember2025February
-35.68%
0
BHVN
CRWD

Volatility

BHVN vs. CRWD - Volatility Comparison

Biohaven Pharmaceutical Holding Company Ltd. (BHVN) has a higher volatility of 14.42% compared to CrowdStrike Holdings, Inc. (CRWD) at 12.15%. This indicates that BHVN's price experiences larger fluctuations and is considered to be riskier than CRWD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%SeptemberOctoberNovemberDecember2025February
14.42%
12.15%
BHVN
CRWD

Financials

BHVN vs. CRWD - Financials Comparison

This section allows you to compare key financial metrics between Biohaven Pharmaceutical Holding Company Ltd. and CrowdStrike Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab